Policy Shifts and Leadership in Retina: CMS GLOBE and EYLEA HD Expansion
February 13, 2026 • Retinal Diseases Content Hub
In this episode of RetinUp, hosts John Kitchens, MD, and Scott Krzywonos discuss the new CMS GLOBE Model, a Medicare Part B drug pricing demonstration project, and the FDA’s expanded label for EYLEA HD now including retinal vein occlusion with potential for monthly dosing, outlining how these changes could affect retina practices financially and clinically. They’re joined by retinal specialist and new Harvard Ophthalmology chair Rishi P. Singh, MD, who reflects on leadership, adapting academic centers to industry and policy shifts, and the future direction of retina care and training.
